Iqos leads the way for PMI, but success in US market remains dependent on FDA

Heated tobacco in Japan and nicotine pouches in the US were among the success stories highlighted by Philip Morris International (PMI) in announcing its latest financial results. But the company appears not to have moved much further with plans to roll out its Iqos heated tobacco product across the US, where it still awaits decisions from the Food and Drug Administration (FDA).

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*